G Erez1, A Tirosh2,3, A Rudich4, V Meiner5, D Schwarzfuchs6, N Sharon7, S Shpitzen8, M Blüher9, M Stumvoll9, J Thiery10, G M Fiedler10, Y Friedlander7, E Leiterstdorf8, I Shai4. 1. Obesity Clinic, Meuhedet Health Services, Jerusalem, Israel. 2. Division of Endocrinology, Diabetes, and Hypertension, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA. 3. Talpiot Medical Leadership Program, Chaim Sheba Medical Center, Tel-Hashomer, Israel. 4. The S. Daniel Abraham Center for Health and Nutrition, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel. 5. Department of Human Genetics, Hadassah-University Hospital, Jerusalem, Israel. 6. Nuclear Research Center Negev, Dimona, Israel. 7. Unit of Epidemiology, Hebrew University-Hadassah School of Public Health, Jerusalem, Israel. 8. Center for Research, Prevention and Treatment of Atherosclerosis, Hadassah-University Hospital, Jerusalem, Israel. 9. Department of Medicine, University of Leipzig, Leipzig, Germany. 10. Institute of Laboratory Medicine, University of Leipzig, Leipzig, Germany.
Abstract
AIMS: Over 75% of obese subjects fail to maintain their weight following weight loss interventions. We aimed to identify phenotypic and genetic markers associated with weight maintenance/regain following a dietary intervention. SUBJECTS AND METHODS: In the 2-year Dietary Intervention Randomized Controlled Trial, we assessed potential predictors for weight changes during the 'weight loss phase' (0-6 months) and the 'weight maintenance/regain phase' (7-24 months). Genetic variation between study participants was studied using single-nucleotide polymorphisms in the leptin gene (LEP). RESULTS:Mean weight reduction was -5.5% after 6 months, with a mean weight regain of 1.2% of baseline weight during the subsequent 7-24 months. In a multivariate regression model, higher baseline high-molecular-weight adiponectin was the only biomarker predictor of greater success in 0- to 6-month weight loss (β = -0.222, P-value = 0.044). In a multivariate regression model adjusted for 6-month changes in weight and various biomarkers, 6-month plasma leptin reduction exhibited the strongest positive association with 6-month weight loss (β = 0.505, P-value < 0.001). Conversely, 6-month plasma leptin reduction independently predicted weight regain during the following 18 months (β = -0.131, P-value < 0.013). Weight regain was higher among participants who had a greater (top tertiles) 6-month decrease in both weight and leptin (+3.4% (95% confidence interval 2.1-4.8)) as compared with those in the lowest combined tertiles (+0.2% (95% confidence interval -1.1 to 1.4)); P-value < 0.001. Weight regain was further significantly and independently associated with genetic variations in LEP (P = 0.006 for both rs4731426 and rs2071045). Adding genetic data to the phenotypic multivariate model increased its predictive value for weight regain by 34%. CONCLUSION: Although greater reduction in leptin concentrations during the initial phase of a dietary intervention is associated with greater weight loss in the short term, plasma leptin reduction, combined with the degree of initial weight loss and with genetic variations in the LEP gene, constitutes a significant predictor of subsequent long-term weight regain.
RCT Entities:
AIMS: Over 75% of obese subjects fail to maintain their weight following weight loss interventions. We aimed to identify phenotypic and genetic markers associated with weight maintenance/regain following a dietary intervention. SUBJECTS AND METHODS: In the 2-year Dietary Intervention Randomized Controlled Trial, we assessed potential predictors for weight changes during the 'weight loss phase' (0-6 months) and the 'weight maintenance/regain phase' (7-24 months). Genetic variation between study participants was studied using single-nucleotide polymorphisms in the leptin gene (LEP). RESULTS: Mean weight reduction was -5.5% after 6 months, with a mean weight regain of 1.2% of baseline weight during the subsequent 7-24 months. In a multivariate regression model, higher baseline high-molecular-weight adiponectin was the only biomarker predictor of greater success in 0- to 6-month weight loss (β = -0.222, P-value = 0.044). In a multivariate regression model adjusted for 6-month changes in weight and various biomarkers, 6-month plasma leptin reduction exhibited the strongest positive association with 6-month weight loss (β = 0.505, P-value < 0.001). Conversely, 6-month plasma leptin reduction independently predicted weight regain during the following 18 months (β = -0.131, P-value < 0.013). Weight regain was higher among participants who had a greater (top tertiles) 6-month decrease in both weight and leptin (+3.4% (95% confidence interval 2.1-4.8)) as compared with those in the lowest combined tertiles (+0.2% (95% confidence interval -1.1 to 1.4)); P-value < 0.001. Weight regain was further significantly and independently associated with genetic variations in LEP (P = 0.006 for both rs4731426 and rs2071045). Adding genetic data to the phenotypic multivariate model increased its predictive value for weight regain by 34%. CONCLUSION: Although greater reduction in leptin concentrations during the initial phase of a dietary intervention is associated with greater weight loss in the short term, plasma leptin reduction, combined with the degree of initial weight loss and with genetic variations in the LEP gene, constitutes a significant predictor of subsequent long-term weight regain.
Authors: Michael Rosenbaum; Krista Vandenborne; Rochelle Goldsmith; Jean-Aime Simoneau; Steven Heymsfield; Denis R Joanisse; Jules Hirsch; Ellen Murphy; Dwight Matthews; Karen R Segal; Rudolph L Leibel Journal: Am J Physiol Regul Integr Comp Physiol Date: 2003-02-27 Impact factor: 3.619
Authors: Paul S MacLean; Janine A Higgins; Matthew R Jackman; Ginger C Johnson; Brooke K Fleming-Elder; Holly R Wyatt; Edward L Melanson; James O Hill Journal: Am J Physiol Regul Integr Comp Physiol Date: 2006-02-02 Impact factor: 3.619
Authors: Y Jiang; J B Wilk; I Borecki; S Williamson; A L DeStefano; G Xu; J Liu; R C Ellison; M Province; R H Myers Journal: Am J Hum Genet Date: 2004-06-11 Impact factor: 11.025
Authors: N Gaukrodger; B M Mayosi; H Imrie; P Avery; M Baker; J M C Connell; H Watkins; M Farrall; B Keavney Journal: J Med Genet Date: 2005-06 Impact factor: 6.318
Authors: Shruti Dasgupta; Mohammed Salman; Lokesh B Siddalingaiah; G L Lakshmi; D Xaviour; Jwalapuram Sreenath Journal: Adipocyte Date: 2014-12-20 Impact factor: 4.534
Authors: Cara B Ebbeling; Janis F Swain; Henry A Feldman; William W Wong; David L Hachey; Erica Garcia-Lago; David S Ludwig Journal: JAMA Date: 2012-06-27 Impact factor: 56.272
Authors: S Jakobsdottir; I C van Nieuwpoort; C C van Bunderen; M B de Ruiter; J W R Twisk; J B Deijen; D J Veltman; M L Drent Journal: Int J Obes (Lond) Date: 2016-05-24 Impact factor: 5.095
Authors: William S Garver; Sara B Newman; Diana M Gonzales-Pacheco; Joseph J Castillo; David Jelinek; Randall A Heidenreich; Robert A Orlando Journal: Genes Nutr Date: 2013-03-08 Impact factor: 5.523